Unknown

Dataset Information

0

Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis.


ABSTRACT: The hot water extract of Rabdosia rubescens was traditionally used as an antithrombotic medicine. To explore its antithrombotic utility and mechanism, we carried out a series of in vitro and in vivo assays in this study. In vitro platelet aggregation assay showed that the half maximal inhibitory concentration values of aqueous extract of R. rubescens leaves (AERL) inhibiting platelet aggregation induced by thrombin, arachidonic acid, adenosine diphosphate, and platelet-activating factor ranged from 0.12 mg/mL to 1.43 mg/mL. The minimal effective oral dose of AERL inhibiting the rats from forming thrombus was 25 mg/kg. Both in vitro and in vivo actions were correlated with AERL concentration-dependently inhibiting sP-selectin release. In water, AERL formed nanoparticles, and their size depended on the concentration. Docking the five nucleotides, 21 phenolic acids, and four diterpenoids identified by high-performance liquid chromatography-photodiode array detector/(-)electrospray ionization-tandem mass spectrometry analysis into the active site of P-selectin, rosmarinic acid was predicted to be the antithrombotic ingredient of AERL. In flow cytometry analysis, 1 ?M of rosmarinic acid effectively inhibited sP-selectin release in arachidonic acid-activated platelets. In a rat model, 5 mg/kg of oral rosmarinic acid effectively inhibited thrombosis.

SUBMITTER: Wang Y 

PROVIDER: S-EPMC4639563 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis.

Wang Yuji Y   Tang Jingcheng J   Zhu Haimei H   Jiang Xueyun X   Liu Jiawang J   Xu Wenyun W   Ma Haiping H   Feng Qiqi Q   Wu Jianhui J   Zhao Ming M   Peng Shiqi S  

International journal of nanomedicine 20151104


The hot water extract of Rabdosia rubescens was traditionally used as an antithrombotic medicine. To explore its antithrombotic utility and mechanism, we carried out a series of in vitro and in vivo assays in this study. In vitro platelet aggregation assay showed that the half maximal inhibitory concentration values of aqueous extract of R. rubescens leaves (AERL) inhibiting platelet aggregation induced by thrombin, arachidonic acid, adenosine diphosphate, and platelet-activating factor ranged f  ...[more]

Similar Datasets

| PRJNA730335 | ENA
| S-EPMC8839758 | biostudies-literature
| S-EPMC9671727 | biostudies-literature
| S-EPMC4554418 | biostudies-literature
| S-EPMC7278658 | biostudies-literature
| S-EPMC4212545 | biostudies-literature
| S-EPMC7398976 | biostudies-literature
| S-EPMC10536318 | biostudies-literature
2024-07-25 | MSV000095442 | MassIVE
| S-EPMC5452754 | biostudies-other